Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
100 studies found for:    Open Studies | "Warfarin"
Show Display Options
Rank Status Study
1 Recruiting Therapeutic Equivalence Between Branded and Generic Warfarin Tablets in Brazil
Condition: Atrial Fibrillation
Interventions: Drug: Marevan®;   Drug: generic warfarin #1;   Drug: generic warfarin #2
2 Recruiting Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves
Conditions: Pregnancy;   Heart; Complications, Valve, Prosthesis
Interventions: Drug: Low Molecular Weight Heparine : Enoxaparine;   Drug: Enoxaparine and 2.5 mg Warfarin;   Drug: Enoxaparine and 4mg Warfarin;   Drug: Warfarin
3 Unknown  Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
Condition: Anticoagulation
Interventions: Drug: warfarin;   Drug: Warfarin
4 Recruiting Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively
Condition: Primary Disease
Interventions: Drug: Dabigatran;   Drug: Warfarin
5 Recruiting Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
Conditions: Cirrhosis;   Hypertension;   Status;Splenectomy;   Venous Thrombosis
Interventions: Drug: Warfarin;   Drug: Dipyridamole;   Drug: Aspirin;   Drug: Low Molecular Weight Heparin  Calcium
6 Recruiting Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
Conditions: Cirrhosis;   Hypertension;   Venous Thrombosis;   Status; Splenectomy
Interventions: Drug: Warfarin;   Drug: Dipyridamole;   Drug: Aspirin;   Drug: Low Molecular Weight Heparin Calcium
7 Recruiting Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Conditions: Anti-coagulation Therapy;   DVT;   Pulmonary Embolism;   Joint Surgery Multiple;   Atrial Fibrillation;   Prosthetic Replacement of Mitral Valve
Intervention: Device: Warfarin GenoSTAT Test
8 Recruiting The Study of Warfarin Maintenance Dose in Chinese Patients
Conditions: Atrial Fibrillation;   Heart Valve Disease;   Pulmonary Artery Embolism
Intervention: Drug: Warfarin
9 Recruiting Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Disease
Interventions: Other: Genotype-guided warfarin dosing;   Other: Non-genotype guided warfarin dosing
10 Recruiting Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
Conditions: Ischemic Stroke;   Transient Ischemic Attack
Interventions: Drug: Rivaroxaban;   Drug: Warfarin
11 Recruiting Cognitive Impairment Related to Atrial Fibrillation Prevention Trial
Condition: Atrial Fibrillation
Interventions: Drug: Warfarin;   Drug: Dabigatran
12 Recruiting Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity
Conditions: Atrial Fibrillation;   Thrombus Due to Heart Valve Prosthesis
Intervention: Drug: Warfarin
13 Recruiting Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
Conditions: Atrial Fibrillation;   Coronary Artery Disease
Interventions: Drug: Ticagrelor+Warfarin;   Drug: Clopidogrel+Aspirin+Warfarin
14 Recruiting Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium
15 Not yet recruiting Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin
Condition: Hypoprothrombinemia
Interventions: Other: Warfarin adjustment using the Fearon algorithm;   Other: Warfarin adjustment using standard dosing
16 Recruiting Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis
Condition: Thrombosis
Interventions: Drug: Warfarin;   Drug: Warfarin + ASA 100 mg + PPI;   Drug: Warfarin + ASA 300 mg + PPI;   Drug: Observational Warfarin
17 Recruiting Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis
Condition: Complications Due to Heart Valve Prosthesis
Interventions: Drug: Acetyl Salicylic Acid;   Drug: Warfarin;   Drug: Placebo (for Aspirin)
18 Not yet recruiting The Secondary Prevention of The Nonvalvular Atrial Fibrillation Combine With Stroke
Conditions: Cardioembolic Stroke;   Atrial Fibrillation
Interventions: Drug: aspirin and hirudin;   Drug: Warfarin
19 Not yet recruiting Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Condition: Atrial Fibrillation
Interventions: Drug: apixaban;   Drug: warfarin
20 Recruiting Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: Dabigatran Etexilate 110mg;   Drug: Warfarin 3mg;   Drug: Aspirin;   Drug: Dabigatran Etexilate 150mg;   Drug: Clopidogrel or Ticagrelor;   Drug: Warfarin 5mg;   Drug: Warfarin 1mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years